BARCLAYS PLC: AVIR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on AVIR, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 348,653 AVIR shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 348,653 sharesChange vs previous 13F +187,707 shares
<0.01% of the 13F portfolio, value $1,621,239.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 160,946 sharesChange vs previous 13F -80,518 shares
<0.01% of the 13F portfolio, value $865,889.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 241,464 sharesChange vs previous 13F +70,152 shares
<0.01% of the 13F portfolio, value $700,246.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 171,312 sharesChange vs previous 13F -28,801 shares
<0.01% of the 13F portfolio, value $512,224.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 200,113 sharesChange vs previous 13F +23,036 shares
<0.01% of the 13F portfolio, value $670,379.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 177,077 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $593,208.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).